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abstract: Human ectopic pregnancy (EP) remains a common cause of pregnancy-related ﬁrst trimester death. Nitric oxide (NO) is
synthesized from L-arginine by three NO synthases (NOS) in different tissues, including the Fallopian tube. Studies of knockout mouse
models have improved our understanding of the function of NOS isoforms in reproduction, but their roles and speciﬁc mechanisms in infec-
tion-induced tubal dysfunction have not been fully elucidated. Here, we provide an overview of the expression, regulation and possible func-
tion of NOS isoforms in the Fallopian tube, highlighting the effects of infection-induced changes in the tubal cellular microenvironment
(imbalance of NO production) on tubal dysfunction and the potential involvement of NOS isoforms in tubal EP after Chlamydia trachomatis
genital infection. The non-equivalent regulation of tubal NOS isoforms during the menstrual cycle suggests that endogenous ovarian steroid
hormones regulate NOS in an isoform-speciﬁc manner. The current literature suggests that infection with C. trachomatis induces an inﬂam-
matory response that eventually leads to tubal epithelial destruction and functional impairment, caused by a high NO output mediated by
inducible NOS (iNOS). Therefore, tissue-speciﬁc therapeutic approaches to suppress iNOS expression may help to prevent ectopic implan-
tation in patients with prior C. trachomatis infection of the Fallopian tube.
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Introduction
Ectopic implantation in the ﬁrst trimester of pregnancy is a common
cause of human maternal morbidity and mortality (Corpa, 2006). It
accounts for 1.5–2% of all pregnancies in the western world (Barn-
hart, 2009), and  97% of ectopic pregnancies (EPs) are in the Fallo-
pian tube (Mukul and Teal, 2007). Tubal EP is a growing problem in
developing countries (Farquhar, 2005; Barnhart, 2009). The mamma-
lian Fallopian tube is a dynamic, steroid-responsive tissue (Jansen,
1984) composed of heterogeneous cell types: ciliated and secretory
epithelial cells as well as smooth muscle cells, all of which appear to
be specialized to perform different functions (Shao et al., 2007a, b).
Tubal abnormalities and dysfunction (e.g. altered abnormal ciliary
activity or contractility) are thought to lead to tubal EP, but the
precise aetiology of its initiation and development is unknown
(Shao, 2010). A major risk factor is previous pelvic inﬂammatory
disease, which is quite common in women with tubal EP (Brunham
and Rey-Ladino, 2005). According to the World Health Organization
(WHO) (http://www.who.int/mediacentre/factsheets/fs110/en/
index.html), 10–40% of women with untreated Chlamydia trachomatis
infection worldwide develop symptomatic pelvic inﬂammatory disease
associated with complications. Women infected with C. trachomatis in
the genital tract are highly susceptible to tubal EP (Chow et al., 1990).
An untreated C. trachomatis infection is likely to injure tissue, cause
permanent scarring and obstruct the Fallopian tubes at multiple sites
(Paavonen and Lehtinen, 1996; Farquhar, 2005) as a consequence of
the host inﬂammatory immune response (Entrican et al., 2004), ulti-
mately inhibiting or disrupting gamete transport. However, the
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90% of women with C. trachomatis infection do not have symptoms
(Peipert, 2003), the WHO has recommended screening strategies
to decrease the C. trachomatis spread and thereby indirectly decrease
the tubal EP rate. In many industrialized countries and China, the
prevalence of C. trachomatis infection is 2–5% of the population
(Fenton et al., 2001; Parish et al., 2003; Miller et al., 2004).
How C. trachomatis infection induces Fallopian tube damage is
poorly understood at the molecular level, and a better understanding
of the biological basis of infection-induced tubal EP is needed to aid its
prevention and treatment. Nitric oxide (NO) is an endogenous short-
lived signalling molecule involved not only in multiple physiological pro-
cesses but also in diseases in different organs/tissues (Moncada and
Higgs, 1991; Moncada et al., 1991), including the Fallopian tube (Ros-
selli et al., 1998). The role of NO in regulating gene expression,
enzyme activity, and transcription factor activation has been exten-
sively demonstrated in several experimental models other than Fallo-
pian tube (Moncada and Higgs, 1991; Moncada et al., 1991). NO is a
double-edged sword. At low levels, it alters intracellular Ca
2+ levels
and activates uterine smooth muscle relaxation (Telfer et al., 1995).
But at high levels, it causes infection-induced immune reaction and
inﬂammation-induced tissue lesions (Moncada and Higgs, 1991;
Moncada et al., 1991; Rosselli et al., 1998).
The purpose of this review is to highlight the potential role of nitric
oxide synthases (NOS) in Fallopian tube physiology and to discuss
how C. trachomatis infection changes the tubal microenvironment by
regulating NO production by different NOS isoforms, leading to
tubal EP. The current review also suggests future research directions.
NO signalling and NOS isoforms
in the Fallopian tube
The diverse biological actions of NO as an intra- and inter-cellular
messenger are mediated by binding to metal-containing centres of
enzymes and by stimulation of the soluble NO-sensitive form of gua-
nylate cyclase (sGC). This event leads to increases in cyclic guanosine
monophosphate (cGMP) levels and activation of cGMP-dependent
protein kinase (PKG) or cGMP-independent intracellular effects in
target cells (Moncada et al., 1991). In the clinic, treatment of vagina
with sildenaﬁl citrate, which inhibits cGMP breakdown, increases
endometrial thickness (Jerzak et al., 2008), which may increase the
chance of successful pregnancy at spontaneous conception or IVF in
recurrent miscarriage patients. As far as caution on cardiovascular
effects of sildenaﬁl in humans is concerned, there is a need for
studies to evaluate toxicities associated with sildenaﬁl treatment, in
particular the human risk assessment, before clinical use of sildenaﬁl
in women with EP.
The precise role of the NO-cGMP signalling pathway in the Fallo-
pian tube is unclear. Rat Fallopian tube cells express a number of
NO-cGMP signalling components, such as sGCa1, sGCb1, PKG1a
and PKG1a (Zhan et al., 2003). The mammalian Fallopian tube is a
site of endogenous production of NO (Rosselli et al., 1998), which
is quickly metabolized to its stable end product, nitrate (Wennmalm
et al., 1993). One clinical study showed a signiﬁcant increase in circu-
lating nitrite/nitrate levels after the luteinizing hormone surge in the
menstrual cycle (Ekerhovd et al., 2001). NO signalling is largely
regulated at the level of NO biosynthesis, and the primary source of
NO production in vivo is oxidation of L-arginine by NOS enzymes
(Alderton et al., 2001).
Three distinct tissue-localized NOS isoforms with predicted mol-
ecular weights of 130–160 kDa have been identiﬁed: calcium-
independent inducible NOS (iNOS), calcium/calmodulin-dependent
neuronal NOS (nNOS) and endothelial NOS (eNOS) (Moncada
and Higgs, 1991; Moncada et al., 1991; Rosselli et al., 1998). NOS iso-
forms are encoded by three distinct genes, exhibit 50–60% amino acid
sequence similarity, and fulﬁl different functions (Nathan and Xie,
1994; Alderton et al., 2001). nNOS and eNOS are constitutively
expressed. iNOS is expressed in response to stimuli (e.g. immune
and inﬂammatory responses) and increased iNOS expression leads
to massive NO production that has both cytotoxic and cytoprotective
effects in a wide range of tissues and cells (Mashimo and Goyal, 1999).
Moreover, activation of nNOS or eNOS results in transient NO
release within seconds or minutes, whereas iNOS generates cellular
production of NO that continues for hours or even days (Moncada
and Higgs, 1991; Moncada et al., 1991).
Studies of the roles of NOS isoforms in NO production and activity
in knockout mouse models indicate that NO activity is maintained at
appropriate levels by a potent NOS network of mechanisms (Tran-
guch and Huet-Hudson, 2003). All nucleated mammalian cells
possess at least one of the three conserved NOS isoforms;
however, their expressions vary in different tissues and cells in vivo
(Bryan et al., 2009) and may reﬂect their biological roles. The three
NOS isoforms are expressed differentially in different cell types of
the Fallopian tube in humans (Rosselli et al., 1996; Ekerhovd et al.,
1997; Tschugguel et al., 1998; Ekerhovd et al., 1999; Machado-Oliveira
et al., 2008; Al-Azemi et al., 2010; Refaat et al., 2009), rats (Bryant
et al., 1995; Chatterjee et al., 1996; Zhan et al., 2003; Kilic et al.,
2008), cattle (Majewski et al., 1995; Rosselli et al., 1996; Lapointe
et al., 2006; Ulbrich et al., 2006) and pigs (Majewski et al., 1995;
Andronowska et al., 1999; Gawronska et al., 2000) (Table I).
However, only tubal epithelial cells express all NOS isoforms,
suggesting that this cell type is a potentially important determinant
of the effects of NO in the Fallopian tube (Table I). Tubal iNOS
and eNOS are the predominant isoforms in both humans and
animals. As discussed below, NOS appears to have physiologically
important, isoform-speciﬁc functions in the Fallopian tube.
Regulation of NOS isoforms in
the Fallopian tube
Although gene expression of NOS isoforms depends on various
factors, hormonal regulation is quite important in the Fallopian tube.
Expression of NOS isoforms and nicotinamide adenine dinucleotide
phosphate-diaphorase (a histochemical, non-speciﬁc marker for all
NOS isoform activities) varies across the normal reproductive cycle
in human, rat, cattle and porcine Fallopian tubes (Bryant et al.,
1995; Chatterjee et al., 1996; Gawronska et al., 2000; Lapointe
et al., 2006; Ulbrich et al., 2006; Al-Azemi et al., 2010). These
results raise the possibility that changes in NOS-derived NO pro-
duction during ﬂuctuating physiological conditions may be involved in
regulation of important Fallopian tube functions, such as ciliary activity
or contractility.
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levels of the major ovarian-derived steroid hormones (17b-estradiol
and progesterone) during the reproductive cycle, local expression of
NOS isoforms may be regulated by 17b-estradiol and/or progester-
one. Indeed, NOS expression and activity in the Fallopian tube are
related to the ratio of 17b-estradiol and progesterone (Rosselli
et al., 1998). Several clinical and experimental observations suggest a
regulatory role for estrogens in the expression of NOS isoforms and
endogenous NO production. First, during follicular development,
increases in estrogen levels are associated with circulating nitrate
levels in reproductive-age women (Rosselli et al., 1994a; Ekerhovd
et al., 2001), and circulating estrogen levels correlate with circulat-
ing/follicular nitrite/nitrate levels during ovarian stimulation in IVF
treatment (Rosselli et al., 1994a; Anteby et al., 1996). Second, in post-
menopausal women, administration of 17b-estradiol signiﬁcantly
increases circulating nitrite/nitrate levels (Ramsay et al., 1995; Cicinelli
et al., 1997). Third, in non-pregnant guinea pigs, the experimental
manipulation of endogenous estrogen levels induces expression of
nNOS and eNOS mRNA and NOS activity in the heart, kidney and
skeletal muscle (Weiner et al., 1994). Fourth, treatment with
17b-estradiol selectively up-regulates iNOS mRNA and protein
expression in the bovine Fallopian tube during the periovulatory
period (Lapointe et al., 2006).
Both genomic and non-genomic effects of estrogen may contribute
to the regulation of NOS isoform expression, but the role of tubal
estrogen receptors in this regulation is poorly characterized. On the
other hand, although the effect of pregnancy on NOS isoform
expression does not support progesterone-mediated induction of
nNOS and eNOS expression (Weiner et al., 1994), progesterone
can up-regulate tissue-dependent iNOS mRNA and protein
expression in pregnant rodents in vivo (Maul et al., 2003). Moreover,
acute in vitro treatment of bovine oviduct epithelial cells with pro-
gesterone rapidly increases iNOS and eNOS mRNA expression
(Ulbrich et al., 2006). Thus, multiple steroid-related mechanisms
may contribute to the overall regulation of NOS isoform expression
and NO production in the Fallopian tube in vivo.
Probing the biological functions
of NOS isoforms
In mammals, NOS activity is highly controlled because its product is a
potent regulator of many physiological processes (Moncada and Higgs,
1991; Moncada et al., 1991; Rosselli et al., 1998). Tubal transport of
the embryo is a complex and highly regulated process, which spans
several days. One line of evidence suggests that NO helps regulate
tubal contractility and relaxation under physiological conditions (Ros-
selli et al., 1996, 1998). In vitro treatment with two NO donors (nitro-
glycerin and spermine NONOate) and 8-bromo cGMP decreased the
contractility of the human Fallopian tube (Ekerhovd et al., 1999). In line
with these ﬁndings, the opposite effect was observed in human and
bovine Fallopian tubes treated with N-nitro-L-arginine methyl ester
(L-NAME), an inhibitor of NO synthesis (Rosselli et al., 1994b; Eker-
hovd et al., 1997). Moreover, local administration of spermine
NONOate abolished the effects of L-NAME, reducing the transport
speed of ovulated oocyte-cumulus complexes in rat Fallopian tubes
(Perez Martinez et al., 2000).
Use of pharmacological blockers of NO synthesis does not dis-
tinguish the competitive inhibitory properties of the three NOS iso-
forms or the diversity of speciﬁc NOS-derived NO production that
.............................................................................................................................................................................................
Table I Summary of reported cell type-speciﬁc differences of NOS isoforms in the Fallopian tube.
Species nNOS iNOS eNOS References
Human Epithelial cells (ampulla) Epithelial cells
a Epithelial cells
a Al-Azemi et al. (2010)
Smooth muscle cells (AIJ, isthmus) Endothelial cells (AIJ, isthmus) Ekerhovd et al. (1997, 1999)
Endothelial cells (AIJ, isthmus) Machado-Oliveira et al. (2008)
Refaat et al. (2009)
Rosselli et al. (1996)
Tschugguel et al. (1998)
Rat Epithelial cells Epithelial cells Epithelial cells
a Bryant et al. (1995)
Smooth muscle cells Chatterjee et al. (1996)
Endothelial cells Kilic et al. (2008)




a Lapointe et al. (2006)
Smooth muscle cells
a Smooth muscle cells
a Smooth muscle cells
a Majewski et al. (1995)
Endothelial cell Rosselli et al. (1996)
Ulbrich et al. (2006)
Porcine Nerve ﬁbre (isthmus) Epithelial cells (ampulla, isthmus) Epithelial cells (ampulla, isthmus) Andronowska et al. (1999)
Endothelial cells (IF, ampulla, isthmus) Endothelial cells (ampulla, isthmus) Gawronska et al. (2000)
Majewski et al. (1995)
AIJ, ampullary isthmic junction; IF, infundibulum; nNOS, neuronal NOS; iNOS, inducible NOS; eNOS, endothelial NOS.
aDemonstrated in the ampulla, AIJ and isthmus.
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iological conditions. Interestingly, the transiently increased iNOS
expression (Shao et al., unpublished data) corroborates reported
increases in circulating NO production (Ekerhovd et al., 2001) and fre-
quency of contraction (Ekerhovd et al., 1999). Taken together, these
results imply that iNOS, rather than nNOS and eNOS, is the major
contributing NOS for local NO production, which might be needed
to suppress tubal transport in the speciﬁc period. Since Fallopian
tubal transport is under precise temporal control by speciﬁc hormonal
and signalling pathways (Jansen, 1984), research is needed to deter-
mine whether tubal transport requires iNOS, and if steroid hormonal
regulation of tubal transport are independent of NOS-derived NO
network.
Key insights into the physiological signiﬁcance of each NOS isoform
have come from gene knockout studies in mice. For example, central
but not ovarian nNOS activity is crucial for ovulation in nNOS-
deﬁcient female mice (Gyurko et al., 2002), whereas studies of
iNOS-deﬁcient female mice have shown that iNOS contributes to
the maintenance of decidual cellular integrity for implantation and
embryo survival (Burnett et al., 2002). In contrast, eNOS-deﬁcient
female mice have a reduced ovulatory capacity, a prolonged oestrous
cycle, impaired early embryonic viability and decreases in implantation
during pregnancy (Tempfer et al., 2000; Heﬂer and Gregg, 2001;
Heﬂer et al., 2001; Pallares et al., 2008). However, typically the del-
etions remove simultaneously more than one NOS gene, hindering
the establishment of genotype-phenotype correlations. In fact,
nNOS-iNOS-, nNOS-eNOS- and iNOS-eNOS-double homozygous
mutant female mice show insufﬁcient alterations of oestrous cyclicity
and fertility (Tranguch and Huet-Hudson, 2003), suggesting that,
when one NOS isoform is deleted, compensatory responses of
other NOS isoforms maintain overall NOS activity in female reproduc-
tive events in vivo.
However, it is not clear how deletion of NOS isoforms, individually
or in combination, affects Fallopian tube function. Furthermore,
isoform-speciﬁc NOS-deﬁcient mouse models show diverse immune
responses (Liu and Huang, 2008). For example, nNOS-deﬁcient
mice are resistant to neuronal inﬂammatory injury, while eNOS-
deﬁcient mice show increased susceptibility to neuronal and vascular
inﬂammatory injury. More interestingly, iNOS-deﬁcient mice show
decreased neuronal inﬂammatory injury and increased susceptibility
to bacterial and viral pathogens (MacMicking et al., 1995; Wei et al.,
1995). These provocative ﬁndings shed light on the mechanisms that
regulate the dynamic expression of different NOS isoforms under
pathophysiological conditions.




Chlamydia are unique obligate intracellular pathogens that can exist in
two forms: the elementary body (EB) and the reticulate body (RB).
EBs, the transmissible form of the organism capable of extracellular
survival, attach to susceptible host cells to initiate infection. After
entering the host cell, the EB induces endocytosis into a host-derived,
membrane-bound vacuole designated as an inclusion. Inside the
inclusion, the EB rapidly differentiates into the non-infective, intracellu-
lar and replicative RB (Muschiol et al., 2006). C. trachomatis has a
unique biphasic developmental cycle, alternating between metaboli-
cally inert EBs and metabolically active RBs (Moulder, 1991). RBs
divide exponentially by binary ﬁssion before condensing back into
EBs, which are released after lysis of infected cells, allowing for
further propagation of the infection (Moulder, 1991).
Chlamydia shares morphological and structural properties of gram-
negative bacteria (Bush and Everett, 2001) and is presented in two
ways: cellular lysis and/or reminiscent exocytosis in host cells
(Hybiske and Stephens, 2007). Human Chlamydia genital infection
causes a wide range of pathologies. In women undergoing microtubo-
plasty for surgical correction of damaged Fallopian tubes, tubal biop-
sies contain Chlamydia (Henry-Suchet et al., 1981; Shepard and
Jones, 1989), and women with tubal factor infertility often have
C. trachomatis DNA or its antigen in the Fallopian tubes (Campbell
et al., 1993). In human Fallopian tube organ culture, C. trachomatis
replicates within both ciliated and non-ciliated epithelial cells
(Cooper et al., 1990). Epithelial cells, but not muscle cells, in the Fal-
lopian tube are the primary targets for Chlamydia infection (Henry-
Suchet et al., 1996; Rasmussen et al., 1997; Igietseme et al., 1998)
and may serve as the ﬁrst line of defence against such infection by reg-
ulating both innate and adaptive immune responses (Wira et al.,
2005a, b). The infected epithelial cells trigger local innate immune
responses for the recognition of invading pathogens through pattern
recognition receptors such as Toll-like receptors (Hart et al., 2009).
A polymorphonuclear leukocyte response is initiated; these cells
produce interleukin (IL) 8 and other proinﬂammatory cytokines (Ras-
mussen et al., 1997) and stimulate the initial neutrophilic response,
which is followed by tissue inﬁltration of macrophages, lymphocyte,
plasma cells and eosinophils (Kuo, 1988).
The important feature of innate immunity is cytokine production,
and regulation of inﬂammation-induced cytokine expression in the Fal-
lopian tube has been demonstrated by several groups. Hess et al.
(2009) demonstrated that epithelial speciﬁc-IL-1b expression in the
Fallopian tubes is higher in women with EP than in those with a
normal menstrual cycle; however, the number of women with EP
who had a Chlamydia infection was not determined. Hvid et al.
(2007) reported that C. trachomatis infection induces epithelial IL-1b
and IL-1 receptor Type I synthesis, which could be blocked by treat-
ment with IL-1 receptor antagonist in human Fallopian tubes. This
group, as well as Prantner et al. (2009), reported that either inhibition
of IL-1b signalling or deletion of IL-1b can prevent pathology in human
Fallopian tubes after infection with C. trachomatis in vitro or in mouse
Fallopian tubes after infection with Chlamydia muridarum, a murine
strain of Chlamydia in vivo. Finally, potential sites for IL-1b synthesis
and secretion are present in macrophages in mouse Fallopian tube
(Prantner et al., 2009). Infections favour macrophage recruitment
and stimulate cytokine synthesis and secretion (La Verda and Byrne,
1994).
Another proinﬂammatory cytokine, tumour necrosis factor-a
(TNF-a), an inﬂammatory central modulator, is also increased in
response to C. trachomatis infection in human Fallopian tubes in vivo
and in vitro (Toth et al., 1992; Ault et al., 1996). Moreover, TNF-a
has an apoptotic role in mouse Fallopian tubes infected with
C. trachomatis in vivo (Perfettini et al., 2000). Thus, epithelial cells
910 Shao et al.and macrophages appear to co-operate to regulate IL-1 and TNF-a
expression and activation, which may be pathogenic in Fallopian
tubes infected with Chlamydia.
The other major proinﬂammatory cytokines and chemokines,
including IL-2, IL-6, IL-8, IL-10, interferon gamma (IFN-g) and granulo-
cyte/macrophage-colony stimulating factor (GM-CSF), are likely
involved in the propagation and progression of inﬂammation in the Fal-
lopian tubes after Chlamydia infection (Rasmussen et al., 1997; Van
Voorhis et al., 1997; Entrican et al., 2004; Strandell et al., 2004;
Hvid et al., 2007). Analysis of patients according to prior exposure
to genital C. trachomatis infection has revealed that the TNFa 308A
allele and the IL-10 1082A allele are risk factors for Fallopian tube
damage in infected women (Ohman et al., 2009), further illustrating
the possibility that cytokines and chemokines mediate tubal damage
induced by C. trachomatis infection.
Inﬂammation is a physiological process used by the organism in
response to infection, tissue damage or cellular irritants (Stutz et al.,
2009). Inﬂammation progresses through different stages. Under
normal circumstance the dynamics of acute inﬂammation are tightly
regulated and self-limited. However, the onset of an unfavourable
chronic inﬂammation by abnormal persistence of a stimulus may
induce tissue damage and impair tissue function. The mechanisms
responsible for Fallopian tube occlusion are not fully understood,
but presumably they involve a combination of chronic inﬂammation
and scarring induced by infections.
Inappropriate regulation of iNOS-derived
NO production facilitates tubal EP
Little is known about the molecular pathogenesis of tubal EP, and in
particular, infection-induced factors (Shao, 2010). Epithelial and
smooth muscle cells are key players in tubal transport (Jansen,
1984; Shao, 2010). Indeed, it has been suggested that initial alterations
in tubal cell mobility, which result in abnormal ciliary activity, epithelial
secretion and contractility, may be responsible for EP. Epithelial cells
and macrophages are the targets of C. trachomatis infection in the Fal-
lopian tube (Henry-Suchet et al., 1996; Rasmussen et al., 1997; Igiet-
seme et al., 1998), highlighting the major cellular sites for the disease.
This link has been strengthened by studies demonstrating that
C. trachomatis infection directly induces loss of microvilli and cilia in
epithelial cells, tubal oedema and extensive disruption of the
mucosal surface in human Fallopian tubes in vitro (Cooper et al.,
1990) and in mice in vivo (Tuffrey et al., 1990). Notably, in mice
with C. muridarum infection, the transport of ovulated oocyte-cumulus
complexes is inhibited by loss of spontaneous contractile activity and
up-regulation of iNOS protein expression in Fallopian tubes in vivo
(Dixon et al., 2009).
iNOS is important because its expression and activity are enhanced
in inﬂammatory immune processes associated with tissue damage
(Nathan and Xie, 1994; Mashimo and Goyal, 1999). Although the
mechanisms linking C. trachomatis infection, iNOS and tubal tissue/
cell destruction are not completely understood, there is evidence
that chronic, intense inﬂammation contributes to tissue remodelling
and scarring in the Fallopian tube (Stephens, 2003; Entrican et al.,
2004), increasing the risk for tubal EP. C. trachomatis infection stimu-
lates the expression of a number of proinﬂammatory cytokines that
reﬂect the induction of inﬂammatory processes, thereby resulting in
Fallopian tube pathology and female infertility (Rasmussen et al.,
1997; Stephens, 2003; Entrican et al., 2004). It is tempting to hypoth-
esize that inﬂammation is a mechanism that links C. trachomatis infec-
tion to tubal EP.
Cytokines produced in the Fallopian tube in response to Chlamydia
infection may regulate iNOS and subsequently generate NO. In fact,
NO is considered to be part of the innate immune response
because it is a bactericidal agent that is lethal to intracellular pathogens
such as C. trachomatis. NO production is a feature of innate immune
cells, such as macrophages and dendritic cells, but NO is also pro-
duced in epithelial cells (Bogdan, 2001). NO production in response
to C. trachomatis infection in the Fallopian tube can be both protective
and pathogenic. NO can participate in microbe-triggered immune
responses within the Fallopian tube; however, their pathological
expression may lead to tubal damage and EP (Refaat et al., 2009).
The ability of C. trachomatis to target both immune and non-immune
cell responses may explain its tendency to establish chronic, latent
infection and cause tissue damage (Stephens, 2003).
In macrophages and other cell types, iNOS expression is transcrip-
tionally induced by stimulation with cytokines or exposure to microbial
products (Xie et al., 1992; Nathan and Xie, 1994). Since both epi-
thelial and smooth muscle cells in the human Fallopian tube express
iNOS (Table I), it is assumed that the tubal cells targeted for cytokine
action by NO production can be the cytokine-producing cell itself (e.g.
epithelial cells) or, through direct release, neighbouring cells such as
macrophages. iNOS-synthesized NO is equally important in human
immune regulation and disease (Nathan and Xie, 1994) but in large
amounts is thought to disrupt cellular signalling cascades, resulting in
anti-inﬂammatory or immunosuppressive effects. Interestingly, iNOS-
deﬁcient mice show greater inﬂammation, more dissemination of
C. trachomatis infection (Igietseme et al., 1998; Ramsey et al., 2001)
and impaired clearance (Perry et al., 1998), demonstrating that
iNOS may contribute to infection-induced immunopathology, rather
than the host immunity against Chlamydia.
It has been suggested that NO is important for implantation and
early pregnancy and activation of inﬂammatory response in mice
(Rosselli et al., 1998; Purcell et al., 1999). If optimally balanced, NOS-
derived NO accumulation is crucial for implantation in rodents
(Barroso et al., 1998; Ota et al., 1999; Purcell et al., 1999; Novaro
et al., 2002). In the Fallopian tube, iNOS is expressed in multiple
cells, where it regulates NO production through autocrine or para-
crine effects. iNOS participates in the growth associated with the
decidual response in the rat uterus (Spencer et al., 1998). The
effects of NO are highly dependent on the local microenvironment,
tissue/cell type and redox state (Rosselli et al., 1998). Although the
cause of tubal EP seems to be multifactorial, NO and iNOS are
likely to contribute to tubal EP because tubal iNOS mRNA and
protein expression is increased in the ampullary region, a site of ferti-
lization, of women with tubal EP (Al-Azemi et al., 2010).
The reason why high levels of NO favour permanent tubal damage,
resulting in tubal EP may be that large and sustained ﬂuxes of NO can
induce cytotoxicity and transcriptional disturbance in various tissues/
cells (Moncada and Higgs, 1991; Moncada et al., 1991). Thus, it is
most likely that cytokine/chemokine-triggered iNOS-derived NO
production in women infected with Chlamydia causes Fallopian tube
scarring and blocks tubal transport by inhibiting ciliary beats and
smooth muscle contractions, ultimately resulting in EP (Fig. 1). If this
NOS and tubal ectopic pregnancy 911is true, it may provide a therapeutic target for suppression of tubal
inﬂammation by manipulation of cytokine and chemokine production
to inhibit the NO pathways.
Further studies are warranted to examine the molecular interaction
between pathophysiological inﬂammatory responses and iNOS-
derived NO regulation after acute and chronic infection with Chlamy-
dia. For example, evaluating cytokine and chemokine production and
secretion under physiological conditions (e.g. normal uterine implan-
tation) or between Chlamydia infection and the onset of tubal
damage in iNOS-deﬁcient mice in vivo and Fallopian tubal tissue
culture in vitro will shed light on the signiﬁcance of NO signalling in
the development of tubal EP induced by Chlamydia infection. Even
though NO protects against infection (Nathan and Xie, 1994;
Bogdan, 2001), iNOS-derived NO overproduction might have dele-
terious consequences for the implanted embryo if there is re-infection
and persistence of Chlamydia. Although no data provide speciﬁc insight
into how implantation occurs in damaged Fallopian tubes after Chlamy-
dia infection, the tubal microenvironment may facilitate the survival of
the implanted embryo (Mastroianni, 1999; Lyons et al., 2006). In view
of the process by which C. trachomatis infection induces tubal EP is
being probably more complicated than a simple step regulation,
there must be research priority to discern how C. trachomatis infection
promotes tubal scarring and/or ﬁbrosis so that appropriate prevention
and treatment strategies may be adopted.
Concluding remarks and
perspective
Tubal EP induced by C. trachomatis infection is still a clinical problem
and the diagnosis remains a challenge. As the complexity of Fallopian
tubal transport under physiological conditions is being revealed
(Jansen, 1984; Shao, 2010), so is the complexity of the mechanisms
responsible for NOS regulation and inﬂammation-related EP after
Chlamydia infection. To our knowledge, obligatory participation of
the different NOS isoforms in the Fallopian tube in a physiological
context has not been deﬁned.
In this brief review, we have attempted to present NOS isoforms, in
particular iNOS, as a component of the NO signalling pathway that is
invoked when tubal cells undergo chronic inﬂammatory processes.
Moreover, cytokines and chemokines produced and released in
response to Chlamydia infection may cause progressive damage and
functional decline of the Fallopian tube, resulting in tubal EP. Although
estrogen can exhibit both anti-inﬂammatory and immunomodulatory
properties in a tissue/cell-speciﬁc manner (Straub, 2007), there is
little evidence for the importance of steroid hormone interactions
with cytokines after Chlamydia infection. However, in contrast to pro-
gesterone (Tuffrey et al., 1990), high levels of endogenous estrogen or
treatment with 17b-estradiol increases resistance to C. trachomatis
infection in mice (Brunham and Rey-Ladino, 2005) and the host estro-
gen receptor complex inﬂuence C. trachomatis attachment in human
endometrial epithelial cells (Davis et al., 2002). Because estrogen
acts through activation of estrogen receptors in the Fallopian tube
(Shao et al., 2007a, b), targeted deletion of estrogen receptor a/b
lowers iNOS expression in female mouse vascular smooth muscle
cells (Liang et al., 2003). Since estrogen up-regulates iNOS expression
in the Fallopian tube, studies of the molecular mechanisms by which
estrogen modulates cell-speciﬁc pro-inﬂammatory cytokine secretion
and NO production are increasing our understanding the role of
estrogen in Fallopian tubal pathology after Chlamydia infection. Such
knowledge might facilitate the development of therapeutic approaches
to mitigate tubal dysfunction.
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